Literature DB >> 15322953

European clinical guidelines for hyperkinetic disorder -- first upgrade.

Eric Taylor1, Manfred Döpfner, Joseph Sergeant, Philip Asherson, Tobias Banaschewski, Jan Buitelaar, David Coghill, Marina Danckaerts, Aribert Rothenberger, Edmund Sonuga-Barke, Hans-Christoph Steinhausen, Alessandro Zuddas.   

Abstract

BACKGROUND: The validity of clinical guidelines changes over time, because new evidence-based knowledge and experience develop.
OBJECTIVE: Hence, the European clinical guidelines on hyperkinetic disorder from 1998 had to be evaluated and modified.
METHOD: Discussions at the European Network for Hyperkinetic Disorders (EUNETHYDIS) and iterative critique of each clinical analysis. Guided by evidence-based information and based on evaluation (rather than metaanalysis) of the scientific evidence a group of child psychiatrists and psychologists from several European countries updated the guidelines of 1998. When reliable information is lacking the group gives a clinical consensus when it could be found among themselves.
RESULTS: The group presents here a set of recommendations for the conceptualization and management of hyperkinetic disorder and attention deficit/hyperactivity disorder (ADHD).
CONCLUSION: A general scheme for practice in Europe could be provided, on behalf of the European Society for Child and Adolescent Psychiatry (ESCAP).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322953     DOI: 10.1007/s00787-004-1002-x

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  149 in total

1.  Stimulant therapy and seizure risk in children with ADHD.

Authors:  S A Hemmer; J F Pasternak; S G Zecker; B L Trommer
Journal:  Pediatr Neurol       Date:  2001-02       Impact factor: 3.372

2.  The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and metaanalyses.

Authors:  A R Jadad; L Booker; M Gauld; R Kakuma; M Boyle; C E Cunningham; M Kim; R Schachar
Journal:  Can J Psychiatry       Date:  1999-12       Impact factor: 4.356

Review 3.  Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.

Authors:  T E Wilens; J Biederman; R J Baldessarini; B Geller; D Schleifer; T J Spencer; B Birmaher; A Goldblatt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-11       Impact factor: 8.829

4.  The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.

Authors:  S Fuke; S Suo; N Takahashi; H Koike; N Sasagawa; S Ishiura
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

5.  Evidence for a pure time perception deficit in children with ADHD.

Authors:  Anna Smith; Eric Taylor; Jody Warner Rogers; Stuart Newman; Katya Rubia
Journal:  J Child Psychol Psychiatry       Date:  2002-05       Impact factor: 8.982

6.  Abnormal early stages of task stimulus processing in children with attention-deficit hyperactivity disorder--evidence from event-related gamma oscillations.

Authors:  J Yordanova; T Banaschewski; V Kolev; W Woerner; A Rothenberger
Journal:  Clin Neurophysiol       Date:  2001-06       Impact factor: 3.708

7.  Brain metabolism in teenagers with attention-deficit hyperactivity disorder.

Authors:  A J Zametkin; L L Liebenauer; G A Fitzgerald; A C King; D V Minkunas; P Herscovitch; E M Yamada; R M Cohen
Journal:  Arch Gen Psychiatry       Date:  1993-05

8.  Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour.

Authors:  E Taylor; R Schachar; G Thorley; H M Wieselberg; B Everitt; M Rutter
Journal:  Psychol Med       Date:  1987-02       Impact factor: 7.723

9.  Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder?

Authors:  Lindsey Kent; Nick Craddock
Journal:  J Affect Disord       Date:  2003-02       Impact factor: 4.839

10.  A comparison of girls and boys with teacher-identified problems of attention.

Authors:  R McGee; S Williams; P A Silva
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-09       Impact factor: 8.829

View more
  174 in total

Review 1.  Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Authors:  Morris Zwi; Hannah Jones; Camilla Thorgaard; Ann York; Jane A Dennis
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  A multidimensional approach to medication selection in the treatment of children and adolescents with ADHD.

Authors:  Atilla Turgay
Journal:  Psychiatry (Edgmont)       Date:  2007-08

Review 3.  Areas for future investment in the field of ADHD: preschoolers and clinical networks.

Authors:  Manfred Döpfner; Aribert Rothenberger; Edmund Sonuga-Barke
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

Review 4.  Do the diagnostic criteria for ADHD need to change? Comments on the preliminary proposals of the DSM-5 ADHD and Disruptive Behavior Disorders Committee.

Authors:  David Coghill; Sarah Seth
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-11-25       Impact factor: 4.785

5.  The risk of overlooking risks.

Authors:  Catherine Barthélémy
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-01       Impact factor: 4.785

Review 6.  Evaluation of Methylphenidate Safety and Maximum-Dose Titration Rationale in Attention-Deficit/Hyperactivity Disorder: A Meta-analysis.

Authors:  Cellina Ching; Guy D Eslick; Alison S Poulton
Journal:  JAMA Pediatr       Date:  2019-07-01       Impact factor: 16.193

7.  Analysis of patients' preferences: direct assessment and discrete-choice experiment in therapy of adults with attention-deficit hyperactivity disorder.

Authors:  Axel C Mühlbacher; Matthias Nübling
Journal:  Patient       Date:  2010-12-01       Impact factor: 3.883

8.  Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder.

Authors:  D Purper-Ouakil; S Cortese; M Wohl; M Asch; E Acquaviva; B Falissard; G Michel; P Gorwood; M C Mouren
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

9.  Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder.

Authors:  Fariba Arabgol; Leily Panaghi; Paria Hebrani
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06-18       Impact factor: 4.785

10.  Coordinating Mental Health Care Across Primary Care and Schools: ADHD as a Case Example.

Authors:  Thomas J Power; Nathan J Blum; James P Guevara; Heather A Jones; Laurel K Leslie
Journal:  Adv Sch Ment Health Promot       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.